Japer Therapeutics Warrants
JSPRW
21 hedge funds and large institutions have $3.07M invested in Japer Therapeutics Warrants in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
22% more capital invested
Capital invested by funds: $2.51M → $3.07M (+$561K)
19% less funds holding
Funds holding: 26 → 21 (-5)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$28.4K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$23.3K |
| 3 |
HF
HRT Financial
New York
|
+$19.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$153K |
| 2 |
ACM
Altium Capital Management
New York
|
-$133K |
| 3 |
AGM
Alpine Global Management
New York
|
-$42K |
| 4 |
LA
Linden Advisors
New York
|
-$29.6K |
| 5 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$11.6K |
JSPRW Hedge Fund Activity: Q2 2021 in Review
21 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q2 2021, worth a combined $3.07M — up 22% from $2.51M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of JSPRW and 1 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Cowen and Company, opening a new position worth an estimated $28.4K. The largest seller was Picton Mahoney Asset Management, exiting entirely with an estimated $153K sold.
- 21 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q2 2021, down from 26 in Q1 2021.
- Funds reported $3.07M of Japer Therapeutics Warrants stock for Q2 2021, up 22% quarter-over-quarter.
- 1 fund opened new Japer Therapeutics Warrants positions in Q2 2021 and 6 closed out, a net change of -5 holders.
- The largest Japer Therapeutics Warrants buyer in Q2 2021 was Cowen and Company, an estimated $28.4K added.
- The largest Japer Therapeutics Warrants seller in Q2 2021 was Picton Mahoney Asset Management, an estimated $153K sold.
Based on aggregated 13F filings for Q2 2021.